Experimental eye cell transplant could slow blindness

NCT ID NCT06789445

First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 28 times

Summary

This study tests a new treatment called OpCT-001 for people with vision loss due to diseases like retinitis pigmentosa. The treatment involves injecting special cells into the eye to replace damaged light-sensing cells. The study has two parts: first to check safety in a small group, then to see if it improves vision in up to 54 adults.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETINAL DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mid Atlantic Retina/ Wills Eye

    RECRUITING

    Philadelphia, Pennsylvania, 19107, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Retina Foundation of the Southwest

    RECRUITING

    Dallas, Texas, 75231, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Miami, Bascom Palmer Eye Institute

    RECRUITING

    Miami, Florida, 33136, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Wisconsin

    RECRUITING

    Madison, Wisconsin, 53705, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.